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Abstract
Background: Hepatoblastoma (HBL) and hepatocellular carcinoma (HCC) are respectively the first and the second
most common pediatric malignant liver tumors. The purpose of this study was to evaluate the combined use of
the ultrasound examination and the assessment of the patients’ clinical features for differentiating HBL from HCC in
children.
Methods: Thirty cases of the confirmed HBL and 12 cases of the confirmed HCC in children under the age of 15
years were enrolled into our study. They were divided into the HBL group and the HCC group according to the
histological types of the tumors. The ultrasonic features and the clinical manifestations of the two groups were
retrospectively analyzed, with an emphasis on the following parameters: onset age, gender (male/female) ratio,
positive epatitis-B-surface-antigen (HBV), alpha-fetoprotein increase, and echo features including septa, calcification
and liquefaction within the tumors.
Results: Compared with the children with HCC, the children with HBL had a significantly younger onset age (8.2
years vs. 3.9 years, P < 0.001) and a significantly smaller frequency of positive HBV (66.7% vs. 13.3%, P < 0.001). The
septa and liquefaction were more frequently found in HBL than in HCC (25/30, 83.3% vs. 2/12, 16.7%, P < 0.001;
17/30, 56.7% vs. 3/12, 25%, P = 0.02). When a combination of the liquefaction, septa, negative HBV and onset age
smaller than 5 years was used in the evaluation, the sensitivity was raised to 90%, the accuracy was raised to 88%,
and the negative predictive value was raised to 73%.
Conclusion: Ultrasonic features combined with clinical manifestations are valuable for differentiating HBL from
HCC in children.
Background
Two-thirds of the pediatric primary liver tumors are
malignant [1,2]. Hepatoblastoma (HBL) accounts for 40-
60% of the liver tumors in children, which is the most
common malignant liver tumor in children [1,3]. Hepato-
cellular carcinoma (HCC) accounts for about 20%, which
is the second most common malignant liver tumor in
children [1,4]. The two malignant liver tumors have
some similar clinical and imaging features but the
prognosis and treatments are quite different. The origin
and nature of the malignant liver tumors should be clear
in order to use a proper treatment. The differential diag-
nosis should be based on the following findings: tumor
encapsulation, calcification presence, current hemor-
rhage, predisposing factors including hepatic fibrosis, and
some clinical information of the patients [5].
Typically, ultrasonography is the first-line imaging
method of evaluating children with liver tumors. But
few studies were performed to describe in detail the dif-
ferentiation between the two types of the tumors, espe-
cially for description on the value of the combined use
of the clinical manifestations and the ultrasound features
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any medium, provided the original work is properly cited.for the differentiation [1-7]. Thus, the purpose of this
study was to evaluate the ultrasound examination com-
bined with the significant clinical manifestations of the
patients in differential diagnosis between HBL and HCC
in children.
Methods
Patients
This study was a retrospective one. Between January
1993 and May 2009, 42 children under 15 years old
(mean age, 5.1 years; age range, 1-15 years) with the
confirmed HBL or HCC were included into our study.
They were divided into the HBL group (n = 30) and the
HCC group (n = 12). The study was approved by the
institutional review board of our hospital (registration
number 20090622) and was in compliance with the Hel-
sinki Declaration. All the children underwent abdominal
ultrasound scanning before treatments. Among the
patients, only 5 (1 with HBL, other 4 with HCC) under-
went contrast CT. None of them underwent contrast
MRI. The HBL group consisted of 13 girls and 17 boys
ranging in age from 1 to 14 years, among which 12
were infected with hepatitis B virus (HBV). The HCC
group consisted of 9 boys and 3 girls ranging in age
from 6 to 15 years, among which 4 were infected with
HBV. Only 5 children were tested for hepatitis C infec-
tion and all were anti-hepatitis-C-virus negative, includ-
ing 3 children with HCC and 2 with HBL. The
pathological diagnoses were obtained by liver biopsy,
postoperative histological examinations or autopsy.
Among the 42 patients, 25 underwent hepatic segmen-
tectomy, lobectomy, trisegmentectomy or liver trans-
plantation. Chemotherapy was given to 30 patients.
In the HBL group, according to the cellular pathology,
17, 6, 3 and 4 patients respectively had a tumor of the
epithelial type, the mixed epithelial/mesenchymal type,
the anaplastic type, and the macrotrabecular type.
Ultrasonic image acquisition and analysis
The patients underwent the ultrasound scan with GE
Logiq 500, HP SONOS 4500, or PHILIPS HD-11 color
Doppler ultrasound diagnostic instruments. An experi-
enced doctor, who had more than 5 years’ work experi-
ence, examined the patients. The probe frequency of the
ultrasound used in our study was 3-5 MHz. The patients
were placed in the supine position, the gray-scale ultra-
sound of the lesion was used. The images were trans-
ferred to the workstation. A series of ultrasound
features of the lesions (number, size, location, calcifica-
tion, liquefaction, septa within the mass), together with
the background liver echo nature, and the conditions of
the portal hepatic venous systems were recorded.
Two experienced ultrasound specialists, respectively
with 19 (Y. Peng) and 17(Y. Luo) years’ work experience
and were blinded to the diagnosis, reviewed the pictures
and recorded a serial of ultrasound features as for the
same contents mentioned above. Discrepancies in the
interpretations between the specialists were resolved by
the consensus.
The lesion numbers were recorded according to the
distribution pattern of the solitary, multiple or diffuse
lesions. To obtain the given size of the liver mass, the
long-axe diameter was measured three times at the cen-
tral section of the mass in the ultrasound images. The
average diameter was calculated, which was regarded as
the final diameter. The location of the lesion was
recorded as the left, right or bi-lobe of the liver. Lique-
faction, calcification and s e p t aw e r eo b s e r v e di nt h e
grey-scale ultrasound images. The diagnosis of liver cir-
rhosis was made if a small and/or nodular liver along
with increased echogenicity and an irregular appearing
was found. The echo nature of the background liver was
recorded as hepatic cirrhosis or not.
Statistical analysis
We performed data analysis on a personal computer
with the SPSS statistical package (version 13.0 for Win-
dows, SPSS Inc., Chicago, IL, USA). Statistical analyses
(t-test, Wilcoxon’s rank sum test, Chi-Square test or
Fisher exact test) were performed to determine the dif-
ferences in the onset age, male/female ratio, hepatitis-B-
surface-antigen (HBS-Ag), alpha-fetoprotein (AFP)
increase, abdominal pain, palpable abdominal lump,
jaundice, lesion size, lesion number, and echo nature
(septa, liquefaction, calcification) within the lesions
between the two groups. A P value of less than 0.05 was
considered statistically significant.
Results
Clinical manifestations
The clinical manifestations of the patients were com-
pared between the HCC and HBL groups (Table 1).
There was no significant difference in the gender ratio
(male/female), jaundice, palpable abdominal lump, AFP
increase or abdominal pain (P >0 . 0 5 ) .B o t ht h eo n s e t
Table 1 Clinical manifestations of HBL and HCC
Clinical manifestation HBL
(n = 30)
HCC
(n = 12)
P
Onset age (yrs) 3.9 ± 2.8 8.2 ± 3.1 < 0.001
Gender ratio* 2.8:1 (22/8) 3:1 (9/3) > 0.05
Palpable abdominal lump 8/30 (26.7%) 4/12 (33%) > 0.05
Abdominal pain 11/30 (36.7%) 4/12 (33%) > 0.05
AFP increase 17/30 (56.7%) 7/12 (58.3%) > 0.05
HBS-Ag positive 4/30 (13.3%) 8/12 (66.7%) < 0.001
Jaundice 17/30 (56.7%) 5/12 (41.7%) > 0.05
HBL: hepatoblatoma; HCC: hepatocellular carcinoma * refers to the male to
female ratio
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between the two groups (P < 0.001). In the histogram
for the onset age of the patients in the HBL group and
t h eH C Cg r o u p ,ad i f f e r e n td i s t r i b u t i o nc o u l db e
observed (Figure 1). The onset age was younger than 5
years in 21 patients of the HBL group, whereas older
than 10 years in 6 children of the HCC group. That is
to say, the average tumor onset-age was younger and
the negative HBS-Ag appeared more frequently in the
children with HBL than in the children with HCC.
Ultrasonic features
The ultrasonic features of HCC and of HBL were listed
in Table 2. There was no significant difference in the
location or the number of the tumor between the two
groups (P > 0.05). The echo within the tumor mass was
significantly different in the septa and the liquefaction
between the two diseases (P < 0.001, P = 0.02 respec-
tively). That is to say, septa and liquefaction were easier
to be found in HBL than in HCC (Figure 2, 3, 4, 5). But
the calcification was occasionally found in both the two
kinds of tumors. The lesion size was significantly differ-
ent between the two groups (P < 0.001). The long-axe
diameters of HBL and HCC were 8.5 ± 3.5 cm and 3.7
± 1.8 cm, respectively. There was no significant differ-
ence in the bile duct, the vessel involvement or the
blood flow condition (P > 0.05). The portal vein throm-
bosis and the hepatic vein thrombosis were observed in
a few cases of HCC. The background liver cirrhosis was
observed only in the children with HCC (Figure 6).
Ultrasonic features combined clinical manifestations for
diagnosis
Based on the ultrasonic features and the clinical mani-
festations, the statistics was made to analyze the diagno-
sis of HBL (Table 3). When a single parameter was
used, e.g., when the negative HBS-Ag was used, sensitiv-
ity of 87% (26/30), specificity of 83% (10/12), and accu-
racy of 83% (35/42) were obtained; when the septa was
used, the positive predictive value (PPV) of 93% (25/27)
and the negative predictive value (NPV) of 67% (10/15)
were obtained; when the negative HBS-Ag was used,
NPV of 67% (8/12) was obtained. However, when a
combination of the liquefaction, septa, onset age (< 5
years) and negative HBS-Ag was used, the sensitivity
was raised to 90%, the accuracy was raised to 88% and
NPV was raised to 73%.
Discussion
Liver tumors are rare in children. Primary liver tumors
account for approximately 1% of the tumors in children.
About 50-60% of the primary liver tumors in children
are malignant, and more than 65% of those malignant
liver tumors are HBL [1-4]. The constant annual inci-
dence of HBL in children is 0.5-1.5 per 1 million in
Western countries [6]. The currently accepted hypoth-
esis is that the HBL cells are derived from the pluripo-
tent hepatic stem cells. Those stem cells retain the
ability to differentiate into both the hepatocytes and the
billiary epithelial cells, and retain the ability to express
markers for both the cell types as a feature in HBL [7].
HCC is the second most common pediatric primary
malignant liver tumors, accounting for about 20% of the
primary liver tumors in children [1,4]. The two diseases
can be treated by chemotherapy and surgical resection,
or by liver transplantation as a last resort [8,9]. It seems
that children with HBL have a better survival rate when
compared with children with HCC [3]. Recently,
Figure 1 Histogram shows the different distributions of
hepatoblastoma (HBL) and hepatocellular carcinoma (HCC)
related to the onset age.
Table 2 Ultrasonic features of HBL and HCC
HBL (n = 30) HCC (n = 12) P
Lesion number
Solitary 22/30 (73.3%) 8/12 (66.7%) > 0.05
Multiple 5/30 (16.7%) 3/12 (25%)
Diffuse 3/30 (10%) 1/12 (8.3%)
Lesion location
Left liver 9/30 (30%) 3/12 (25%) > 0.05
Right liver 13/30 (43.3%) 5/12 (41.7%)
Bi-lobe 8/30 (26.7%) 4/12 (33.3%)
Lesion echo
Liquefaction 17/30 (56.7%) 3/12 (25%) = 0.02
Calcification 4/30 (13.3%) 2/12 (16.7%) > 0.05
Septa 25/30 (83.3%) 2/12 (16.7%) < 0.001
Lesion size 8.5 ± 3.5 cm 3.7 ± 1.8 cm < 0.001
Blood vessel involvement
PVT 0/30 (0%) 2/12 (17%) > 0.05
HVT 0/30 (0%) 1/12 (8.3%) > 0.05
Liver cirrhosis 0/30 (0%) 4/12 (33.3%) < 0.001
PVT: portal vein thrombosis; HVT: hepatic vein thrombosis
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completely [7].
The results of this study have indicated that children
with HCC have a higher incidence of the positive HBV
than those with HBL. Many studies have revealed that
HBV is related to HCC in children. HBV has been con-
sidered a major etiological factor of HCC in children
beyond the age of 4 years [10]. However, little is known
about the etiology of HBL. The most well-established
risk factors of HBL are Beckwith-Wiedemann syndrome,
family history of familial adenomatous polyposis, low
birth weight, and smoking by either or both of the par-
ents [7]. This may explain the different incidence of the
HBV infection related to HBL and HCC in children in
this study.
HBL was mainly a tumor occurring in early childhood
[6,7], and 30-50% of the HBL cases occurred in the first
year of childhood and 50-90% before the age of 5 years
[2,3,6,7]. The onset age of HCC was older than that of
HBL in children. Lee, et al. reported that there was an
HCC onset peak at 12 years old [10]. In our series, the
average HBL onset-age was 2.9 years, but the average
HCC onset-age was 9.3 years. Frequently, HCC was one
of the long-term results of chronic viral infection [11].
And 80% of the HCC cases developed in the cirrhotic
livers [12]. In developing countries, young patients were
apt to suffer from chronic hepatitis B virus infection
[13,14]. The time from liver cirrhosis to HCC might be
the main reason for the older onset-age of HCC. In our
study, positive HBV was found in 66.7% of the HCC
Figure 2 HBL in the right lobe of the liver in a 2-year-old girl.
A grey scale ultrasound image revealed the septa within the lesions
(arrow).
Figure 3 HBL in the right lobe of the liver in a 2-year-old girl.
Photomicrograph (original magnification, 180×; hematoxylin-eosin
stain) revealed a fibrous band (F) between the fetal (arrow) and the
embryonic (arrow head) type of the HBL cells.
Figure 4 HBL in the right lobe of the liver in a 4-year-old boy.
The liquefaction (arrow) was observed in the center of the tumor
and some blood signals were also observed.
Figure 5 HBL in the right lobe of the liver in a 4-year-old boy.
Photomicrograph (original magnification, 90×; hematoxylin-eosin
stain) demonstrated some fibrous bands (arrow) and necrosis (N)
within the tumor.
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have supported the idea that HBV is a major etiological
factor of HCC in children beyond the age of 4 years.
There are more boys than girls who suffered from
HBL or HCC, which was one of the common character-
istics of those two types of tumors occurring in children
[15]. The results of our study have also supported this
finding. The imaging study is important in evaluation
liver neoplasms. CT, MRI and ultrasound are the most-
commonly-used modalities for pediatric doctors in their
medical researches as well as their clinical practice.
Ultrasound is accepted as a first-line imaging method
because of its less irradiation, greater convenience and
better real-time [16]. Ultrasound is extremely valuable
in detecting much smaller lesions, especially in detecting
fluid and blood-flow in a lesion, and it also can evaluate
the hepatic vascular anatomy [17]. As a rule, the initial
diagnosis of live tumor is usually made by the abdom-
inal ultrasound examination. Complete surgical resec-
tion is a key to the permanent cure of the disease, and
so ultrasound examination can be used to exactly loca-
lize the tumor and assess the extent of the tumor devel-
opment. Scintigraphy with 99mTc-labelled monoclonal
anti-AFP is mainly used in the tumor staging. However,
the clinical usefulness of this technique for HBL is not
completely clear [16].
The lesion sizes were significantly different between
the two groups. The long-axe diameter of HBL was
greater than that of HCC. The younger onset-age of the
tumor was a possible reason. The children with HBL
could not tell exactly about their early symptoms, so the
diagnosis was made relatively late. Although the average
long-axe diameter of HBL was greater than that of
HCC, there were some overlaps between the two
groups. Therefore, the lesion size could not be used as
an important indicator for differentiating HBL from
HCC.
The two types of tumors in this study had some simi-
larities in the ultrasound features. Firstly, most of the
lesions in both HBL and HCC groups were located in
the right lobe of the liver in more than 40% of the
cases. Our study showed that the location of HBL was
similar to that reported in the previous studies, in which
the tumor location was in the right lobe of the liver in
60-70% of the HBL cases [7,12]. Secondly, most of the
patients with HBL or HCC had solitary lesions (66.7% in
the HCC group, 73.3% in the HBL group), which coin-
cided with what the medical literature had reported
[12]. However, these two diseases had many different
imaging features. Dachman, et al. reported that liquefac-
tion might be caused by intralesional necrosis or hemor-
rhage [12]. Typically, ultrasound could identify
liquefaction as a hypoechoic area at the center of the
lesion. In our series, liquefaction appeared in 25% of the
HCC cases but appeared in 56.7% of the HBL cases;
therefore, a significant difference could be observed
between the two groups. So, liquefaction could be con-
sidered significant for the HBL diagnosis.
Calcification occurred in such liver diseases as HBL,
HCC, teratoma and involuting haemangioma. So, calcifi-
cation was not a specific indicator in the differential
diagnosis [17]. Calcification might cause acoustic sha-
dowing, which was better depicted by CT or ultrasound
rather than MRI [8]. Microscopically, the calcification
presence on radiographs was often associated with the
Figure 6 HCC in the right lobe of the liver in a 10-year-old boy
with hepatic cirrhosis after the HBV infection. A diffusely-
distributed heterogeneous mass (arrow) with no septa or
liquefaction was revealed at a setting of cirrhosis.
Table 3 Significant ultrasonic and clinical findings for HBL
Ultrasonic & clinical finding Sensitivity
(%)
Specificity
(%)
Accuracy
(%)
PPV
(%)
NPV
(%)
Liquefaction (1) 57(17/30) 75 (9/12) 62 (26/42) 85(17/20) 41 (9/22)
Septa (2) 83 (25/30) 83 (10/12) 83(35/42) 93(25/27) 67(10/15)
Onset age
< 5 yrs(3)
70 (21/30) 58 (7/12) 67(28/42) 81(21/26) 44(6/16)
HBS-Ag negative (4) 87 (26/30) 67 (8/12) 81(34/42) 80(24/30) 67(8/12)
(1)+(2)+(3)+(4) 90 (27/30) 83 (10/12) 88(37/42) 93(27/34) 73(8/11)
Numbers in parentheses: case number; PPV: positive predictive value;
NPV: negative predictive value; yrs: years
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often related to the mixed type of HBL, and the reason
was probably that there was a formation of the osteoid
foci [12]. Calcification rarely occurres in the HCC
patients, which is related to the radiation therapy [13].
Jha, et al. [2] reported that calcification was observed in
about 40% of the HCC cases and observed in 50% of the
HBL cases [2,8]. Our study showed that calcification was
occasionally found in the two kinds of tumors that had
not been treated before. But our study still failed to give
any evidence that calcification is a specific indicator in
the imaging studies for a differentiation of HBL from
HCC. The reason for the great difference in calcification
between the two groups might be that there were quite
a few cases of the mixed epithelial/mesenchymal type of
tumors.
Septa were formed by the fibrous tissue band around
or inside the lesions. Histologically, HBL is usually pre-
sent as a solitary large solid mass, which could contain
fibrous bands, leading to a “spoked-wheel appearance”
[2]. The typical fibrous septa could be observed in the
grey-scale ultrasound images in our study. A previous
case-study suggested that in a multifocal setting, the
presence of a dominant lobulated mass was a clue to
the diagnosis of HBL [8]. In our series, the septa were
more commonly observed in untreated HBL than in
HCC. Thus, this ultrasound feature can be used as an
indicator for differentiating HBL from HCC. Among the
ultrasonic and clinical features of the HBL lesions, the
negative HBS-Ag was the most sensitive parameter, and
the septa were the most specific parameter. When a
combination of liquefaction, septa, onset age (< 5 years)
and negative HBS-Ag was used, the sensitivity was
raised to 90%, the accuracy was raised to 88%, and the
negative predictive value was raised to 73%.
Our study still had some limitations including a long
duration (1993-2009) of the materials collection. Besides,
at the beginning of the study, the Color Doppler Flow
Imaging (CDFI) and elastography were not introduced
into the practice. Whereas contrast enhanced ultrasound
(CEUS) has already been mature in the diagnosis of the
liver occupying lesions in recent years, childhood is still
a contraindication to the contrast agent SonoVue. Thus,
we were unable to give enough information about the
CDFI, CEUS and elastography manifestation of HBL and
HCC in children. But we think that our finding is still
valuable for the pediatric physicians.
Conclusion
In summary, HBL is more likely to develop in children
younger than 5 years, with negative HBS-Ag and ultra-
sonic manifestation of a mass that has septa and lique-
faction. HCC usually develops in older children with an
HBV infection, with a liver solid mass, which has no
liquefaction or septa. Ultrasound is the first-line imaging
method to be used in a child with a suspected liver
tumor, and this imaging method can provide informa-
tion to help decide the use of the clinical treatment.
Ultrasonic features combined with clinical manifesta-
tions are valuable for differentiating HBL from HCC in
children.
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